| Daniel Harmon, | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (800) 822-8816 | |
| Not Available |
| Full Name | Daniel Harmon |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 21 Years |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962610709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 26456 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
A report produced today by Primary Care National Director, Dr David Colin-Thome, shows that NHS primary care, the local healthcare people access most frequently, is continuing to expand and provide a wider range of services to patients.
Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced that clinical data for simeprevir, its NS3/4A protease inhibitor for the treatment of hepatitis C virus (HCV) infection, will be presented at The International Liver Congress 2015 of the European Association for the Study of the Liver taking place in Vienna from April 22-26.
The relevance of positron emission tomography (PET) alone or in combination with computed tomography (CT) in patients with malignant melanoma cannot be currently assessed due to a lack of meaningful studies. This is the result of a final report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 20 July 2011.
The U.S. Food and Drug Administration today recommended more conservative dosing guidelines for Erythropoiesis-Stimulating Agents (ESAs) when used to treat anemia in patients with chronic kidney disease (CKD) because of the increased risks of cardiovascular events such as stroke, thrombosis, and death.
› Verified 4 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
A report produced today by Primary Care National Director, Dr David Colin-Thome, shows that NHS primary care, the local healthcare people access most frequently, is continuing to expand and provide a wider range of services to patients.
Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced that clinical data for simeprevir, its NS3/4A protease inhibitor for the treatment of hepatitis C virus (HCV) infection, will be presented at The International Liver Congress 2015 of the European Association for the Study of the Liver taking place in Vienna from April 22-26.
The relevance of positron emission tomography (PET) alone or in combination with computed tomography (CT) in patients with malignant melanoma cannot be currently assessed due to a lack of meaningful studies. This is the result of a final report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 20 July 2011.
The U.S. Food and Drug Administration today recommended more conservative dosing guidelines for Erythropoiesis-Stimulating Agents (ESAs) when used to treat anemia in patients with chronic kidney disease (CKD) because of the increased risks of cardiovascular events such as stroke, thrombosis, and death.
› Verified 4 days ago
| Entity Name | Baptist Health Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265496236 PECOS PAC ID: 3476457011 Enrollment ID: O20180124001442 |
News Archive
A report produced today by Primary Care National Director, Dr David Colin-Thome, shows that NHS primary care, the local healthcare people access most frequently, is continuing to expand and provide a wider range of services to patients.
Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced that clinical data for simeprevir, its NS3/4A protease inhibitor for the treatment of hepatitis C virus (HCV) infection, will be presented at The International Liver Congress 2015 of the European Association for the Study of the Liver taking place in Vienna from April 22-26.
The relevance of positron emission tomography (PET) alone or in combination with computed tomography (CT) in patients with malignant melanoma cannot be currently assessed due to a lack of meaningful studies. This is the result of a final report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 20 July 2011.
The U.S. Food and Drug Administration today recommended more conservative dosing guidelines for Erythropoiesis-Stimulating Agents (ESAs) when used to treat anemia in patients with chronic kidney disease (CKD) because of the increased risks of cardiovascular events such as stroke, thrombosis, and death.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Harmon, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | Daniel Harmon, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
A report produced today by Primary Care National Director, Dr David Colin-Thome, shows that NHS primary care, the local healthcare people access most frequently, is continuing to expand and provide a wider range of services to patients.
Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced that clinical data for simeprevir, its NS3/4A protease inhibitor for the treatment of hepatitis C virus (HCV) infection, will be presented at The International Liver Congress 2015 of the European Association for the Study of the Liver taking place in Vienna from April 22-26.
The relevance of positron emission tomography (PET) alone or in combination with computed tomography (CT) in patients with malignant melanoma cannot be currently assessed due to a lack of meaningful studies. This is the result of a final report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 20 July 2011.
The U.S. Food and Drug Administration today recommended more conservative dosing guidelines for Erythropoiesis-Stimulating Agents (ESAs) when used to treat anemia in patients with chronic kidney disease (CKD) because of the increased risks of cardiovascular events such as stroke, thrombosis, and death.
› Verified 4 days ago
Walter J Oakes, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Charles H Clark Iii, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 St Vincents Drive, #700, Birmingham, AL 35205 Phone: 205-933-8981 Fax: 205-930-0746 | |
Walter George Haynes Iii, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 513 Brookwood Blvd, Ste. 75, Birmingham, AL 35209 Phone: 205-250-6805 Fax: 205-250-6580 | |
Dr. Brandon G Rocque, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Lowder 400, Birmingham, AL 35233 Phone: 205-638-9653 | |
Matthew Scott Erwood, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 Saint Vincents Dr Ste 700, Birmingham, AL 35205 Phone: 205-933-8981 Fax: 205-930-0746 | |
Dr. Chad Claus, D.O. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
James Michael Johnston Jr., M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-939-9100 |